Explore Products

PAK4 inhibition significantly potentiates Gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways

  • AcceGen R&D Team
  • Feb 07, 2024
  • 19

You Might Also Like

AcceGen Scroll Top Button